Question 12413 — diseases

Summary

Mr. Richard Ramos questions the Minister of Solidarity and Health about Lyme disease. The number of people affected by Lyme disease has increased significantly in recent years. The creation of the PNDS, while it constitutes progress in the management of the disease and better consideration of patients, nevertheless leaves gray areas on certain points. Thus, it appears essential that the ministry clarifies them, so that patients have clear answers to their questions. Thus, many voices are being raised in the medical field regarding the reliability of the Elisa test, administered primarily to people who need to be screened. The test reveals false negatives and leads to medical wandering for many patients. The Western Blot test, administered secondly, appears much more reliable and therefore satisfactory. However, for why is this test not prescribed in the first place? The lymphocyte transformation test is recommended in Germany, but not in France. However, according to many specialists, this test makes it possible to verify that an infection is active or that the patient's treatment has been effective. So, if this test proves effective in these two cases, why is it not recommended in France? Recognize that Lyme disease is chronic would also be a major advance in recognizing patient symptoms. The High Health Authority recognizes SPPT if the symptoms have been present for more than 6 months and occur several times a week, which is progress, however, it still does not accept the term “chronic Lyme” implying the presence of live borrelia after antibiotic treatment. However, borrelia can survive in the organism and then resurface after treatment. So, what should we say to patients when they relapse? He asks him what the Government's position is on these questions.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.